CD14 and neoplasm: Monocytes after membrane fusion with TEX gain a new phenotype without human leukocyte antigen-DR (HLA-DR) expression and costimulatory molecule upregulation but with CD14 expression, called CD14+HLA-DRlo/neg monocytes and have emerged as important mediators of tumor-induced immunosuppression [104].